Accelerating and widening access to safe, effective and innovative health technologies that bring value to patients and the healthcare system is essential for improving health outcomes, reducing disparities, and ensuring sustainable, patient-centered care in an increasingly complex and resource-constrained healthcare environment.
Collaboratively develop a clear roadmap for evidence generation to support submissions and acceptance from regulators and HTA bodies.
Build and implement relevant, robust and reliable digital measures for drug development & clinical care.
Avoid unnecessary duplication in regulatory and HTA processes by profiling the different requirements and developing a consensus-based framework for a patient-centered, DHT-derived endpoints.
Improve time to market and acceptance of innovative health technologies by using validated DHTs.
Mission members (interested parties) will select a use case to serve as a proof of concept on how:
Q1 to Q4 2026
Scope:
1) Simulation Workshop
2) Case Study Generation
3) Evaluation and Proof of Concept
4) Submit to NICE
5) Review Outcomes
Join DEEP and other sponsors on this mission to take the right steps towards successful HTA interactions!
Interested in joining this mission or need more information? Contact us.
Sign up for our newsletter to receive the latest solutions, new opportunities and expert insights on digital health measures delivered to your inbox.